Alembic Pharmaceuticals Ltd
NSE:APLLTD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Alembic Pharmaceuticals Ltd
NSE:APLLTD
|
IN |
|
E
|
Eiffage SA
XBER:EF3
|
FR |
|
Molecular Templates Inc
NASDAQ:MTEM
|
US |
|
Huicheng International Holdings Ltd
OTC:COUTF
|
CN |
|
H
|
Headstrong Group Inc
OTC:HDST
|
US |
|
T
|
Thumzup Media Corp
OTC:TZUP
|
US |
|
Amarc Resources Ltd
XTSX:AHR
|
CA |
|
M
|
Mineralbrunnen Ueberkingen-Teinach GmbH & Co KgaA
SWB:MUT
|
DE |
|
B
|
BMO Real Estate Investments Ltd
LSE:BREI
|
UK |
|
Block Inc
F:SQ3
|
US |
|
C
|
Consensus Asset Management AB (publ)
F:5XI
|
SE |
|
Superior Gold Inc
XTSX:SGI
|
CA |
|
Wedia SA
PAR:ALWED
|
FR |
|
Softec SpA
MIL:YSFT
|
IT |
|
I'rom Group Co Ltd
TSE:2372
|
JP |
|
A
|
Arena.pl SA
WSE:ARE
|
PL |
|
Cyber App cCorp
OTC:CYRB
|
KR |
Wall Street
Price Targets
APLLTD Price Targets Summary
Alembic Pharmaceuticals Ltd
According to Wall Street analysts, the average 1-year price target for
APLLTD
is 1 007.42 INR
with a low forecast of 853.45 INR and a high forecast of 1 338.75 INR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is APLLTD's stock price target?
Price Target
1 007.42
INR
According to Wall Street analysts, the average 1-year price target for
APLLTD
is 1 007.42 INR
with a low forecast of 853.45 INR and a high forecast of 1 338.75 INR.
What is Alembic Pharmaceuticals Ltd's Revenue forecast?
Projected CAGR
11%
For the last 13 years the
compound annual growth rate for
Alembic Pharmaceuticals Ltd's revenue is
12%.
The projected
CAGR
for the next 3 years is
11%.
What is Alembic Pharmaceuticals Ltd's Operating Income forecast?
Projected CAGR
21%
For the last 13 years the
compound annual growth rate for
Alembic Pharmaceuticals Ltd's operating income is
11%.
The projected
CAGR
for the next 3 years is
21%.
What is Alembic Pharmaceuticals Ltd's Net Income forecast?
Projected CAGR
21%
For the last 13 years the
compound annual growth rate for
Alembic Pharmaceuticals Ltd's net income is
12%.
The projected
CAGR
for the next 3 years is
21%.
